Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Editorial Board Member: Gillery, Philippe / Kazmierczak, Steven / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Whitfield, John B.

12 Issues per year


IMPACT FACTOR 2013: 2.955
Rank 5 out of 29 in category Medical Laboratory Technology in the 2013 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR): 0.860
Source Normalized Impact per Paper (SNIP): 1.046

VolumeIssuePage

Issues

Limits and pitfalls of Athlete's Biological Passport

1IRCCS Galeazzi and University of Milan, Milan, Italy

Corresponding author: Giuseppe Banfi, IRCCS Galeazzi and University of Milan, Via Galeazzi 4, 20161 Milan, Italy Phone: +390266214829, Fax: +390266214048

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 49, Issue 9, Pages 1417–1421, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2011.633, May 2011

Publication History

Received:
2011-04-11
Accepted:
2011-05-06
Published Online:
2011-05-28

Abstract

The Athlete's Biological Passport (ABP) is an evaluation of hematological parameters, hemoglobin (Hb), reticulocytes (Ret), and their combination in the OFF-score. Recently, the Court of Arbitration for Sport accepted it as a suitable indirect method for detecting blood doping. There are various topics which are not defined and scientifically completely explained in ABP, limiting its effectiveness as evidence and as suspect of blood manipulation. The data source the ABP used for designing a profile is unclear. The variance used for cyclists is not correct. The covariables which should be calculated together with the measures of Hb and Ret are not always considered in the statistical program. The pre-analytical warnings for correct and valid collection, transport, and storage of the specimens are not assured. Quality control of the instruments is not completely assured. Analytical variability is not appropriately considered in the program. The seasonal changes of the hematological parameters, due to training and competitions, are not calculated. Statistical analysis, based on a Bayesian-like program, not available to the scientific community, does not follow the classical decision-making approach of medicine and science. The ABP needs of additional evidences and of scientific debate.

Keywords: athletes; athlete's biological passport; blood doping; hemoglobin; reticulocytes

Comments (0)

Please log in or register to comment.
Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.